Immunization with rLm-gp33 did protect against virus replication and spread of MHV antigen in the CNS, in a perforin-dependent manner. However, despite the fact that gp33 epitope escape mutants were readily selected, virus was cleared with similar kinetics as in naive mice, that is, within the first week to 10 days postinfection.